CRMD FY 2019 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena

CRMDCorMedix Inc.

$518M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$283,266-34.1% YoY

Gross Profit

-$89,968-31.8% margin

Operating Income

-$21M-7416.3% margin

Net Income

-$16M-5801.3% margin

EPS (Diluted)

$-0.68

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$15M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$29M

Total Liabilities

$6M

Stockholders' Equity

-$195M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$283,266	$429,797	-34.1%
Gross Profit	-$89,968	$33,011	-372.5%
Operating Income	-$21M	-$27M	+21.8%
Net Income	-$16M	-$27M	+38.8%